Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.09%
+1.10%
-0.44%
UTHR
United Therapeutics Corpo
$433.34
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Outperform the market
Chart
$434.06 (-0.17%)
$298.14 (+45.35%)
$320.37 (+35.26%)
$374.02 (+15.86%)
UTHR has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
UTHR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Reported a strong earnings
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
UTHR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
UTHR Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
What is UTHR current stock price?
What are UTHR stock strengths?
What risks are associated with UTHR stock?
When is UTHR next earnings report?
What is UTHR market cap and volume?
What is UTHR's current Stock IQ?
Should I buy UTHR stock right now?
Is UTHR a Strong Buy right now?
What does a 'Strong Buy' rating mean for UTHR?
What does a 'Strong Sell' rating mean for UTHR?
What factors influence UTHR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.09%
+1.10%
-0.44%
UTHR
United Therapeutics Corpo
Current Price
$433.34
Stock Insights
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Outperform the market
Chart
$434.06 (-0.17%)
$298.14 (+45.35%)
$320.37 (+35.26%)
$374.02 (+15.86%)
UTHR Analysts Opinion
UTHR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Reported a strong earnings
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
UTHR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
UTHR Street view is extremely bullish and have positive views on the near-term outlook
UTHR has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
UTHR Latest Analysis
Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case. United Therapeutics Corporation (NASDAQ:UTHR) is one of the best stocks to buy according to Jim Simons Renaissance Technologies. On October 2 Jefferies reiterated its Buy rating and a price target of $564 for United Therapeutics Corporation (NASDAQ:UTHR). This decision comes amid ongoing legal proceedings related to a patent dispute. The patent dispute involves interpretations of [….]
Thu Oct 16, 2025
Is IPF the Next Big Market Opportunity for United Therapeutics?. UTHR reports strong TETON-2 results for Tyvaso in IPF showing lung function gains and eyeing a major new market.
Wed Oct 1, 2025
UBS Maintains United Therapeutics (UTHR) Buy Recommendation. Fintel reports that on September 29 2025 UBS maintained coverage of United Therapeutics (NasdaqGS:UTHR) with a Buy recommendation. Analyst Price Forecast Suggests 9.28% Upside
Mon Sep 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
UTHR Stock trends
UTHR Stock performance
UTHR Stock analysis
UTHR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.